Press Release: Cooperation on medicines regulation intensified

The EU-FDA confidentiality arrangement was reviewed at a meeting in Brussels on 13 March 2006 at a meeting of the European Commission, the European Medicines Agency (EMEA) and the US Food and Drug Administration (FDA). This review resulted in an agreement to intensify transatlantic cooperation in the area of medicinal products, with particular focus on vaccines (including preparedness for influenza pandemic), medicines for children, medicines for rare diseases, oncology and pharmacogenomics.